Ownership history in BARCLAYS PLC · 44 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in BIOHAVEN PHARMACTL HLDG CO L (BHVN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 100 | -320,746 | -100.0% | 0.00% | $1K | $11.29 |
| 2025 Q4 | REDUCED | 320,846 | -25,998 | -7.5% | 0.00% | $3.6M | $11.29 |
| 2025 Q3 | REDUCED | 346,844 | -74,056 | -17.6% | 0.00% | $5.2M | $15.01 |
| 2025 Q3 | ADDED | 420,900 | +315,300 | +298.6% | 0.00% | $6.3M | $15.01 |
| 2025 Q3 | REDUCED | 105,600 | -241,563 | -69.6% | 0.00% | $1.6M | $15.01 |
| 2025 Q2 | ADDED | 347,163 | +183,556 | +112.2% | 0.00% | $4.9M | $14.11 |
| 2025 Q1 | REDUCED | 163,607 | -229,120 | -58.3% | 0.00% | $3.9M | $24.04 |
| 2024 Q4 | ADDED | 392,727 | +124,650 | +46.5% | 0.00% | $14.7M | $37.35 |
| 2024 Q3 | ADDED | 268,077 | +125,189 | +87.6% | 0.00% | $13.4M | $49.97 |
| 2024 Q2 | ADDED | 142,888 | +56,954 | +66.3% | 0.00% | $5.0M | $34.71 |
As of 2025 Q4 — sorted by position size